Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
Cardiovascular Diabetology, 06/25/09
Alokail MS et al. – Obesity and type 2 diabetes, owing to their effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in premenopausal women. This study emphasizes healthy life style and better management of these metabolic disorders to avoid the pathogenesis of breast cancer and of other chronic diseases.
Methods- Study to determine the association between obesity and type 2 diabetes with BCa risk in premenopausal women
- Women (n=101) were categorized as obese, overweight and normal body weight based on BMI
- Serum levels of IL-6, TNF-α CRP, leptin, TGF-α adiponectin and insulin were measured by ELISA
- Data were logarithmically transformed for variables not normally distributed
- Analysis of variance with post-hoc Bonferroni was applied to compare the data between the groups
- Increased levels of IL-6, CRP, leptin and decreased levels of adiponectin were found in obese group
- Levels of TNF-α and TGF-α were unaltered
- A positive correlation between waist circumference and IL-6 was found in obese group
- Similarly, CRP, waist and hip circumferences were linearly correlated with BMI in obese group
- Stepwise multiple linear regression analysis revealed several significant predictors for BCa risk
Related Articles
Obesity, intentional weight loss and physical disability in older adults
Obesity Reviews, 11/18/09
Relevance Score: 94%
Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09
Relevance Score: 94%
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Relevance Score: 94%
Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09
Relevance Score: 93%
Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09
Relevance Score: 93%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Psychometric properties and responsiveness of the Turkish version of the Diabetes Treatment Satisfaction Questionnaire (s) on a sample of diabetics of three consecutive monitoring periods
Acta Diabetologia, 11/25/09
Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men
Acta Diabetologia, 11/25/09
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
The prognostic impact of general and abdominal obesity in peripheral arterial disease
International Journal of Obesity, 11/25/09
Low Levels of Plasma Agmatine in the Metabolic Syndrome
Metabolic Syndrome and Related Disorders, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


